Novel Procedures for Validating Surrogate Endpoints in Clinical Trials

E-ISSN： 2212-3938|2|2|123-128

ISSN： 1574-8847

Source： Current Clinical Pharmacology, Vol.2, Iss.2, 2007-05, pp. : 123-128

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Surrogate Efficacy Endpoints in Oncology Trials

By Markman Maurie

Pharmaceutical Medicine, Vol. 23, Iss. 5-6, 2009-10 ,pp. : 283-287

Adis International

Access to resources Recommend Favorite

Composite Endpoints for Clinical Trials: Current Perspectives

By Kleist Peter

International Journal of Pharmaceutical Medicine, Vol. 21, Iss. 3, 2007-01 ,pp. : 187-198

Adis International

Access to resources Recommend Favorite

Statistical Considerations for Testing Multiple Endpoints in Group Sequential or Adaptive Clinical Trials

By Hung H. M. James

Journal of Biopharmaceutical Statistics, Vol. 17, Iss. 6, 2007-11 ,pp. : 1201-1210

Taylor & Francis Ltd

Access to resources Recommend Favorite

Multistage and Mixture Parallel Gatekeeping Procedures in Clinical Trials

By Dmitrienko Alex

Journal of Biopharmaceutical Statistics, Vol. 21, Iss. 4, 2011-07 ,pp. : 726-747

Taylor & Francis Ltd

Access to resources Recommend Favorite

Sample Size Determination in Superiority Clinical Trials with Multiple Co-Primary Correlated Endpoints

By Sozu Takashi

Journal of Biopharmaceutical Statistics, Vol. 21, Iss. 4, 2011-07 ,pp. : 650-668

Taylor & Francis Ltd

Access to resources Recommend Favorite